Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Radiation Oncology, Biology, Physics|October 15, 1994
Bromodeoxyuridine-mediated radiosensitization in human glioma: the effect of concentration, duration, and fluoropyrimidine modulationP W McLaughlin, T S Lawrence, H Seabury, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1996
Preliminary experience with paclitaxel for the treatment of relapsed and refractory Hodgkin's diseaseA Younes, F Cabanillas, P W McLaughlin, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 1997
Results of 3D conformal radiotherapy in the treatment of localized prostate cancerN Fukunaga-Johnson, H M Sandler, P W McLaughlin, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 1993
Halogenated pyrimidine sensitization of low dose rate irradiation in human malignant gliomaP W McLaughlin, W R Mancini, P L Stetson, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2000
Prostate position late in the course of external beam therapy: patterns and predictorsR C Zellars, P L Roberson, M Strawderman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1986
Tumor burden assessment and its implication for a prognostic model in advanced diffuse large-cell lymphomaS Jagannath, W S Velasquez, S L Tucker, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2002
Comparison of MRI pulse sequences in defining prostate volume after permanent implantationP W McLaughlin, V Narayana, D G Drake, et al.
Clinical and Translational Radiation Oncology|July 11, 2022
Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatmentZachary A Seymour, Stephanie Daignault-Newton, P W McLaughlin, et al.
International Journal of Radiation Oncology, Biology, Physics|February 25, 1999
Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteriaC S Ha, V Kavadi, M A Dimopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2011
A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndromeS Vadhan-Raj, L E Fayad, M A Fanale, et al.
Pageof 4